MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0011506
Mercure Pharmaceuticals (OPC) Private Limited
Mercure Pharmaceuticals (OPC) Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹85,541
▲ 4% YoY
Net profit · FY 2025
₹971
Net margin 1.1%
EBITDA · FY 2025
₹3,660
EBITDA margin 4.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹2.94 Cr
Satisfied ₹6.41 Cr
Company age
10 yrs
Est. 2016
Directors on board
1
As per MCA filings
About Mercure Pharmaceuticals (OPC) Private Limited
Data last updated:
Mercure Pharmaceuticals (OPC) Private Limited is a one person company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2016OPC041240. Its GSTIN is 23AAKCM5173D1ZM (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Siddhant Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 46 2nd Floor Dawa Bazar, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹85,541, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹971 (net margin 1.1%) and EBITDA of ₹3,660 (EBITDA margin 4.3%). Revenue has declined at a compounded annual rate (CAGR) of 91% over three years and 78% over five years.
As per MCA filings, the company has open charges of ₹2.94 Cr and satisfied charges of ₹6.41 Cr on record.
Mercure Pharmaceuticals (OPC) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0011506). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290MP2016OPC041240
Registration Number 041240
Incorporation Date 01 August 2016
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0011506
Key People
Siddhant Jain Director Recognitions & Rankings of Mercure Pharmaceuticals
Contact details
Mercure Pharmaceuticals (OPC) Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address46 2nd Floor Dawa Bazar, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mercure Pharmaceuticals (OPC) Private Limited, buy the company report.
Comprehensive company report
Mercure Pharmaceuticals (OPC) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Mercure Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mercure Pharmaceuticals (OPC) Private Limited, buy the company report.
Financials of Mercure Pharmaceuticals (OPC) Private Limited
FY 2025 filings availableMercure Pharmaceuticals (OPC) Private Limited reported revenue of ₹85,541 (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹85,541 ▲ 4%
Net profit · FY 2025
₹971 margin 1.1%
EBITDA · FY 2025
₹3,660 margin 4.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 91%
5 years · compounded
▼ 78%
EBITDA CAGR growth
1 year
▲ 26%
3 years · compounded
▼ 90%
5 years · compounded
▼ 73%
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 78%. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,660 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹971 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mercure Pharmaceuticals (OPC) Private Limited, buy the company report.
Board of directors of Mercure Pharmaceuticals (OPC) Private Limited
Mercure Pharmaceuticals has 1 director on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddhant Jain | Director | 01 Aug 2016 | 10 Years 3 Months | Current |
Peer comparison
Mercure Pharmaceuticals (OPC) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mercure Pharmaceuticals (OPC) Private Limitedthis company | ₹85,541 (FY 2025) | ₹971 | 1.1% | 4.0% | Indore, Madhya Pradesh, India | |
| Savio Remidies Pharmaceuticals Private Limited | ₹85,506 (FY 2024) | -76.0% | Jabalpur, Madhya Pradesh, India | |||
| Bioxima Pharmaceuticals Private Limited | ₹85,392 (FY 2021) | -32.0% | New Delhi, Delhi, India | |||
| Sheer Health Pharmaceuticals Private Limited | ₹84,989 (FY 2023) | -62.0% | Roorkee, Uttarakhand, India |
To see the full peer comparison of Mercure Pharmaceuticals (OPC) Private Limited, buy the company report.
Auditor
Mercure Pharmaceuticals (OPC) Private Limited is audited by S G N & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S G N & CO | FY 2023 | 134565W |
Shareholding
The shareholding of Mercure Pharmaceuticals (OPC) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mercure Pharmaceuticals (OPC) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.94 Cr
Satisfied charges
₹6.41 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Feb 2025 | 101053077 | Others | ₹2.76 Cr | Open | |
| 30 Dec 2023 | 100899725 | Others | ₹18 Lakh | Open | |
| 25 Feb 2021 | 100423192 | Hdfc Bank Limited | ₹3.2 Cr | Satisfied | |
| 25 Jun 2020 | 100354278 | Others | ₹31 Lakh | Satisfied | |
| 13 Jun 2019 | 100272600 | Others | ₹2.9 Cr | Satisfied |
To see the full charge records of Mercure Pharmaceuticals (OPC) Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Mercure Pharmaceuticals (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mercure Pharmaceuticals (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mercure Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAKCM5173D1ZM | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mercure Pharmaceuticals (OPC) Private Limited, buy the company report.
Recent activity
Mercure Pharmaceuticals (OPC) Private Limited has 1 board change on record since 2016: 1 appointment. The latest: Siddhant Jain was appointed as Director on 01 Aug 2016.
AGM
Mercure Pharmaceuticals (Opc) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mercure Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others amounted to Rs. 276.00 Lakh with Charge ID 101053077 was registered on 20 Feb 2025.
Charges
A charge with Others amounted to Rs. 18.00 Lakh with Charge ID 100899725 was registered on 30 Dec 2023.
Charges
A charge registered on 25 Jun 2020 via Charge ID 100354278 with Others was fully satisfied on 22 Jul 2022.
Charges
A charge registered on 13 Jun 2019 via Charge ID 100272600 with Others was fully satisfied on 22 Jul 2022.
Charges
A charge registered on 25 Feb 2021 via Charge ID 100423192 with Hdfc Bank Limited was fully satisfied on 25 Apr 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 320.00 Lakh with Charge ID 100423192 was registered on 25 Feb 2021.
Charges
A charge with Others amounted to Rs. 31.00 Lakh with Charge ID 100354278 was registered on 25 Jun 2020.
Charges
A charge with Others amounted to Rs. 290.00 Lakh with Charge ID 100272600 was registered on 13 Jun 2019.
Appointed
Siddhant Jain was appointed as Director.
Incorporation
01 Aug 2016
Mercure Pharmaceuticals (Opc) Private Limited was registered on 01 Aug 2016 with Roc Gwalior & aged 10 years 3 months as per MCA records.
Frequently asked questions
Mercure Pharmaceuticals is an active company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 August 2016 (10+ years old) and is registered under CIN U24290MP2016OPC041240.
Mercure Pharmaceuticals has 1 current director:
- Siddhant Jain - Director
The latest financial statements of Mercure Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Mercure Pharmaceuticals is 23AAKCM5173D1ZM, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Mercure Pharmaceuticals is U24290MP2016OPC041240. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mercure Pharmaceuticals was incorporated on 01 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Mercure Pharmaceuticals by revenue are Savio Remidies Pharmaceuticals Private Limited, Bioxima Pharmaceuticals Private Limited, Sheer Health Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Siddhant Jain was appointed as Director on 01 Aug 2016.
Yes, Mercure Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0011506).
The registered office of Mercure Pharmaceuticals is at 46 2nd Floor Dawa Bazar, Indore, Madhya Pradesh, India – 452001.
Mercure Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages